Jinyu Bio-technology Co., Ltd. (SHA:600201)
6.80
-0.13 (-1.88%)
Apr 30, 2025, 3:00 PM CST
Jinyu Bio-technology Revenue
Jinyu Bio-technology had revenue of 351.57M CNY in the quarter ending March 31, 2025, a decrease of -7.29%. This brings the company's revenue in the last twelve months to 1.35B, down -17.64% year-over-year. In the year 2023, Jinyu Bio-technology had annual revenue of 1.60B with 4.55% growth.
Revenue (ttm)
1.35B
Revenue Growth
-17.64%
P/S Ratio
5.63
Revenue / Employee
816.23K
Employees
1,654
Market Cap
7.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.60B | 69.56M | 4.55% |
Dec 31, 2022 | 1.53B | -247.65M | -13.94% |
Dec 31, 2021 | 1.78B | 194.41M | 12.29% |
Dec 31, 2020 | 1.58B | 455.12M | 40.39% |
Dec 31, 2019 | 1.13B | -769.83M | -40.59% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |